Position
Pfizer Inc in Oric Pharmaceuticals, Inc.
Back to the book · All holders of ORIC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $18.5M$8.18 → $12.06
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 5.38M | $44M | — | — | — | 18.6% |
| Q1 2026 | 4.78M | $57.7M | $12.06 | $18.5M | −$4.87M | 24.1% |